Fused Pyrimidine-Based Drug Discovery

About the author

Dr. Raj Kumar, FRSC, is currently working as Dean of School of Health Sciences, and a Professor at the Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Bathinda, India. He obtained his Ph.D. in Medicinal Chemistry (2007) from NIPER, Mohali, India and completed his postdoctoral fellowship (2007-2008) at the University of Maryland Baltimore County (UMBC), Maryland where he co-invented a fused heterocycle RK-33 (Raj Kumar-33) molecule for the treatment of Lung Cancer. Dr. Kumar has published more than 90 peer-reviewed research papers (h index = 33; Scopus) in leading Medicinal/Organic/Pharmaceutical Chemistry Journals with a cumulative impact factor > 300. Dr. Kumar has been featured in the list of top 2% international scientists “Updated Science-wide Database of Stanford Citation Indicators” released by Stanford University, USA and published by Elsevier BV on 19th October 2021. His research interests focus on the design and synthesis of novel fused heterocycles of biological importance.

Product details

• Assisted by: Kumar Raj (Editor)
• Publisher: Elsevier
• Languages: English
• Product format: Paperback / Softback
• Released: 11.10.2022
• EAN: 9780443186165
• ISBN: 978-0-443-18616-5
• Weight: 1000 g
• Series: Heterocyclic Drug Discovery
• Subjects: Natural sciences, medicine, IT, technology > Chemistry > Organic chemistry; ORGANIC CHEMISTRY, SCIENCE / Chemistry / Organic